DeepCurrents Investment Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-51,249
| Closed | -$3.37M | – | 149 |
|
|
2024
Q4 | $3.37M | Sell |
51,249
-20,486
| -29% | -$1.35M | 0.11% | 106 |
|
|
2024
Q3 | $5.04M | Sell |
71,735
-45,447
| -39% | -$3.19M | 0.15% | 105 |
|
|
2024
Q2 | $9.65M | Sell |
117,182
-18,166
| -13% | -$1.5M | 0.38% | 79 |
|
|
2024
Q1 | $11.8M | Sell |
135,348
-17,836
| -12% | -$1.56M | 0.46% | 64 |
|
|
2023
Q4 | $14.8M | Buy |
153,184
+5,047
| +3% | +$487K | 0.54% | 60 |
|
|
2023
Q3 | $13.1M | Buy |
148,137
+4,329
| +3% | +$383K | 0.57% | 56 |
|
|
2023
Q2 | $12.5M | Sell |
143,808
-49,925
| -26% | -$4.33M | 0.49% | 57 |
|
|
2023
Q1 | $18.8M | Buy |
193,733
+6,297
| +3% | +$612K | 0.73% | 40 |
|
|
2022
Q4 | $19.4M | Buy |
187,436
+12,053
| +7% | +$1.25M | 0.75% | 39 |
|
|
2022
Q3 | $14.9M | Buy |
175,383
+16,312
| +10% | +$1.38M | 0.57% | 54 |
|
|
2022
Q2 | $13.2M | Buy |
159,071
+28,216
| +22% | +$2.34M | 0.53% | 55 |
|
|
2022
Q1 | $10.1M | Buy |
+130,855
| New | +$10.1M | 0.31% | 68 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 94 |
|
|
2020
Q2 | – | Sell |
-63,460
| Closed | -$5.36M | – | 100 |
|
|
2020
Q1 | $5.36M | Sell |
63,460
-12,017
| -16% | -$1.02M | 0.26% | 58 |
|
|
2019
Q4 | $6.38M | Buy |
75,477
+42,986
| +132% | +$3.63M | 0.29% | 55 |
|
|
2019
Q3 | $2.19M | Sell |
32,491
-14,110
| -30% | -$951K | 0.15% | 60 |
|
|
2019
Q2 | $3.99M | Sell |
46,601
-17,617
| -27% | -$1.51M | 0.34% | 56 |
|
|
2019
Q1 | $5.7M | Sell |
64,218
-80,591
| -56% | -$7.16M | 0.49% | 41 |
|
|
2018
Q4 | $12.3M | Buy |
+144,809
| New | +$12.3M | 1.53% | 21 |
|